Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06230445
PHASE3

Effects of Digital Therapeutic in Whole Process Management of Lung Cancer

Sponsor: Sun Yat-sen University

View on ClinicalTrials.gov

Summary

This trial will randomize patients into two groups, the treatment group will use the digital therapeutic application named 'UHealth' for the whole process management and the control group will use regular follow-up. The trial aims to look into the difference between quality of life, anxiety/depression index, emergency treatment times, hospital admission rate, treatment compliance, OS, DFS and follow-up cost.

Official title: A Phase 3, Randomized, Open-label Trial of Digital Therapeutic vs Regular Follow-up in Whole Process Management of Lung Cancer

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

900

Start Date

2023-06-01

Completion Date

2028-09-01

Last Updated

2024-02-26

Healthy Volunteers

No

Interventions

OTHER

UHealth digital therapeutic

UHealth digital therapeutic is an application that patients can report their symptoms. If the contents that patients fill in reach the threshold, UHealth application will automatic report to doctor and the doctor will give medical advisement through UHealth digital therapeutic application.

Locations (1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China